In a nation where the battle against the stomach bulge is as intense as the love for butter parathas, a new player has ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk for a much-awaited entry into the world's most populous country grappling ...

The various trials covered time periods ranging from 40 to 52 weeks and included three different strengths of Mounjaro: 5 mg, 10 mg, and 15 mg. The primary endpoint for all the SURPASS trials was ...

Mounjaro is a prescription weight loss injection. Its active ingredient, tirzepatide, plays a key role in regulating appetite and improving insulin function. Mounjaro improves blood sugar levels ...

Eli Lilly and Company launched its weight loss drug Mounjaro in India on Thursday after ... One single vial of 2.5 mg will cost Rs. 3500 and one single vial of 5 mg will cost Rs.